secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dogwood Therapeutics, Inc. (DWTX)
CIK:        0001818844
Form:       8-K
Filed at:   2024-05-07T23:59:59+00:00
Accession:  0001558370-24-007096
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Virios receives Nasdaq deficiency notice for bid price; requests hearing to seek compliance extension
--------------------------------------------------------------------------------

- Second Nasdaq letter received May 1, 2024 for failure to maintain $1.00 minimum bid price.
- Initial 180-day compliance period expired April 30, 2024; company has requested a hearing to stay delisting.
- Plan to regain compliance includes IMC-2 Long-COVID study data from Bateman Horne Center and potential reverse stock split.
- Hearing before Nasdaq panel will determine extension; common stock (VIRI) remains listed pending decision.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818844/000155837024007096/0001558370-24-007096-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818844/000155837024007096/tmb-20240501x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-007096

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer